Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NASDAQ

$7.14

$+0.29

(+4.26%)

Regular Market

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Live Price Chart

Last updated: ⁦2026-09-16 14:42:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Corbus Pharmaceuticals Holdings, Inc. (CRBP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $7.14, with a market capitalisation of $156.28M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.33 to $20.56. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$156.28M
Open	$6.86
Day's High	$323.40
Day's Low	$2.11
Previous Close	$6.92
Volume	488.95K
Average Volume	667.73K
P/E Ratio	--
52-Week High	$20.56
52-Week Low	$6.33
Dividend Yield	--
Earnings Date	--

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Price Today

Corbus Pharmaceuticals Holdings, Inc. (CRBP) is currently trading at $7.14 as of 2026-09-16 14:26:07, up 3.19% ($0.22) from the previous close of $6.92

During today's regular trading session, CRBP has traded between $2.11 and $323.40, with a trading volume of 488.95K shares. The current price is near the lower end of today's range.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) 7-Day Stock Price Change

Over the past seven days, Corbus Pharmaceuticals Holdings, Inc. (CRBP) moved from $11.08 to $7.14, representing a decline of 35.55% ($3.94).

The stock traded between $6.33 and $11.45 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 2.47 million shares, up versus the previous seven-day period, indicating higher trading activity.

CRBP 52-Week Price Position

Position in Range: 5.7%

52W Low$6.33

52W High$20.56

CRBP is currently trading at $7.14, placing it 5.7% of the way from its 52-week low of $6.33 to its 52-week high of $20.56. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Corbus Pharmaceuticals Holdings, Inc. (CRBP)?

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Corbus Pharmaceuticals Holdings, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	36
Exchange	NASDAQ
Company Website	https://www.corbuspharma.com

How to Buy Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock on MEXC

Eligible investors can buy real shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CRBP and Place Your Order

Open the RealStocks trading page and search for CRBP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock price today?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) is currently trading at $ 7.14, up 3.19% ($0.22) from the previous close of $ 6.92. Intraday prices update in real time during regular trading hours.

2.Is CRBP stock going up or down today?

As of 2026-09-16 14:26:07, CRBP is trading at $ 7.14, up 3.19% ($0.22) from its previous close of $ 6.92. The stock has traded between $ 2.11 and $ 323.40 during today’s regular session. Past price movements do not guarantee future results.

3.What is CRBP pre-market price?

As of 2026-09-16 14:26:07, CRBP is trading at $ 6.87 in pre-market trading, down 0.66% ($0.05) from the previous close of $ 6.92. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CRBP after-hours price?

As of 2026-09-16 14:26:07, CRBP is trading at $ 6.88 in after-hours trading, down 0.59% ($0.04) from the regular-session close of $ 6.92. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CRBP stock trading now?

CRBP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CRBP sit relative to its 52-week high and low?

Over the past 52 weeks, CRBP has traded between a low of $ 6.33 and a high of $ 20.56. At $ 7.14, the stock is positioned 5.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Corbus Pharmaceuticals Holdings, Inc. in?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Corbus Pharmaceuticals Holdings, Inc.'s market capitalisation and where is it listed?

Corbus Pharmaceuticals Holdings, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 156.28M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CRBP valued in terms of P/E ratio and EPS?

CRBP trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -5.27. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Corbus Pharmaceuticals Holdings, Inc. pay a dividend?

Corbus Pharmaceuticals Holdings, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.